Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jan 15, 2007 (Vol. 27, No. 2)

The Genomics Web Page

URL:www.genomics.co.uk
  • Interesting collection of links
  • Could cover genomics more thoroughly
Speaking of Horizon Press-related sites, this one appears to have some connection, as witnessed by its appearance and its links back to the Horizon Press site. In some ways this site is better—less of a focus on commercial sites—and in some ways it is worse—not quite as broad of a scope. Everything is a trade-off, I suppose, and it was that compromise that convinced me this site was worthy of mention. Link topic areas include Analysis of DNA/Protein Sequences, Genomic Institutes, Companies, Books, and Other. In contrast to the previous site, this one seemed to have a much higher percentage of links to places that had nothing to do with trying to sell you something. Curiously, many of the listed books appeared to have no link at all, so I’m not sure what to make of that. A useful, if somewhat puzzling, site.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »